We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

127 hedge funds and large institutions have $359M invested in Spectrum Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 27

6% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 17

3% more capital invested

Capital invested by funds: $349M → $359M (+$9.47M)

1% more funds holding

Funds holding: 126127 (+1)

57% less call options, than puts

Call options by funds: $887K | Put options by funds: $2.05M

Holders
127
Holders Change
+1
Holders Change %
+0.79%
% of All Funds
3.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
56
Reduced
27
Closed
17
Calls
$887K
Puts
$2.05M
Net Calls
-$1.16M
Net Calls Change
-$678K
Name Holding Trade Value Shares
Change
Change in
Stake
BFA
1
BlackRock Fund Advisors
California
$38.5M +$956K +122,127 +3%
Millennium Management
2
Millennium Management
New York
$38.2M +$32.1K +4,100 +0.1%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$34.5M
Vanguard Group
4
Vanguard Group
Pennsylvania
$32.3M +$1.75M +223,427 +6%
State Street
5
State Street
Massachusetts
$24.6M +$1.9M +242,896 +9%
BIT
6
BlackRock Institutional Trust
California
$16M +$369K +47,193 +2%
Bank of Montreal
7
Bank of Montreal
Ontario, Canada
$12.3M +$122K +15,560 +1%
Goldman Sachs
8
Goldman Sachs
New York
$10.4M +$432K +55,263 +5%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$10.1M -$28.7K -3,673 -0.3%
RCAMU
10
Rothschild & Co Asset Management US
Connecticut
$8.82M -$229K -29,217 -3%
Barclays
11
Barclays
United Kingdom
$8.26M -$15.3K -1,958 -0.2%
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$8.17M -$297K -37,911 -4%
ACM
13
Ashford Capital Management
Delaware
$8.09M +$1.75M +223,600 +29%
Federated Hermes
14
Federated Hermes
Pennsylvania
$7.89M -$262K -33,525 -3%
Wellington Management Group
15
Wellington Management Group
Massachusetts
$7.44M +$91K +11,625 +1%
Northern Trust
16
Northern Trust
Illinois
$6.07M -$38.2K -4,886 -0.7%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$4.85M +$245K +31,336 +6%
Charles Schwab
18
Charles Schwab
California
$4.34M +$2.22M +283,288 +113%
TA
19
Teachers Advisors
New York
$4.09M +$3.21M +410,800 +445%
Wells Fargo
20
Wells Fargo
California
$4.01M +$2.1M +267,988 +119%
Macquarie Group
21
Macquarie Group
Australia
$3.31M +$699K +89,376 +28%
FLAM
22
First Light Asset Management
Minnesota
$3.08M +$83.3K +10,647 +3%
Principal Financial Group
23
Principal Financial Group
Iowa
$3.01M +$99K +12,652 +4%
PAM
24
Panagora Asset Management
Massachusetts
$2.8M -$61.9K -7,908 -2%
Citadel Advisors
25
Citadel Advisors
Florida
$2.7M +$2.14M +273,202 +465%

SPPI Hedge Fund Activity: Q3 2014 in Review

127 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2014, worth a combined $359M — up 2.7% from $349M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new SPPI positions and 17 closed out — a net gain of 1 holder — while 56 added to existing stakes and 27 trimmed.

The largest buyer was Teachers Advisors, adding an estimated $3.21M. The largest seller was Kennedy Capital Management, exiting entirely with an estimated $6.94M sold.

  • 127 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2014, up from 126 in Q2 2014.
  • Funds reported $359M of Spectrum Pharmaceuticals Inc stock for Q3 2014, up 2.7% quarter-over-quarter.
  • 18 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2014 and 17 closed out, a net change of +1 holder.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q3 2014 was Teachers Advisors, an estimated $3.21M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q3 2014 was Kennedy Capital Management, an estimated $6.94M sold.

Based on aggregated 13F filings for Q3 2014.